» Articles » PMID: 35632546

Targeting Membrane Trafficking As a Strategy for Cancer Treatment

Overview
Date 2022 May 28
PMID 35632546
Authors
Affiliations
Soon will be listed here.
Abstract

Membrane trafficking is emerging as an attractive therapeutic strategy for cancer. Recent reports have found a connection between Wnt signaling, receptor-mediated endocytosis, V-ATPase, lysosomal activity, and macropinocytosis through the canonical Wnt pathway. In macropinocytic cells, a massive internalization of the plasma membrane can lead to the loss of cell-surface cadherins, integrins, and other antigens that mediate cell-cell adhesion, favoring an invasive phenotype. V-ATPase is a key regulator in maintaining proper membrane trafficking, homeostasis, and the earliest developmental decisions in the vertebrate development model system. Here, we review how the interference of membrane trafficking with membrane trafficking inhibitors might be clinically relevant in humans.

Citing Articles

Multi-bioinformatics revealed potential biomarkers and repurposed drugs for gastric adenocarcinoma-related gastric intestinal metaplasia.

Andersen G, Ianevski A, Resell M, Pojskic N, Rabben H, Geithus S NPJ Syst Biol Appl. 2024; 10(1):127.

PMID: 39496635 PMC: 11535201. DOI: 10.1038/s41540-024-00455-0.


Na,K-ATPase activity promotes macropinocytosis in colon cancer via Wnt signaling.

Tejeda-Munoz N, Azbazdar Y, Sosa E, Monka J, Wei P, Binder G Biol Open. 2024; 13(5).

PMID: 38713004 PMC: 11139033. DOI: 10.1242/bio.060269.


Membrane trafficking in breast cancer progression: protein kinase D comes into play.

Gutierrez-Galindo E, Yilmaz Z, Hausser A Front Cell Dev Biol. 2023; 11:1173387.

PMID: 37293129 PMC: 10246754. DOI: 10.3389/fcell.2023.1173387.


Using Machine Vision of Glycolytic Elements to Predict Breast Cancer Recurrences: Design and Implementation.

Petty H Metabolites. 2023; 13(1).

PMID: 36676966 PMC: 9866082. DOI: 10.3390/metabo13010041.


Modulation of Cytoskeleton, Protein Trafficking, and Signaling Pathways by Metabolites from , and Plant Families.

Patel A, Rasheed A, Reilly I, Pareek Z, Hansen M, Haque Z Pharmaceuticals (Basel). 2022; 15(11).

PMID: 36355554 PMC: 9698530. DOI: 10.3390/ph15111380.

References
1.
Ramirez C, Hauser A, Vucic E, Bar-Sagi D . Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis. Nature. 2019; 576(7787):477-481. PMC: 7048194. DOI: 10.1038/s41586-019-1831-x. View

2.
Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

3.
Gopal Krishnan P, Golden E, Woodward E, Pavlos N, Blancafort P . Rab GTPases: Emerging Oncogenes and Tumor Suppressive Regulators for the Editing of Survival Pathways in Cancer. Cancers (Basel). 2020; 12(2). PMC: 7072214. DOI: 10.3390/cancers12020259. View

4.
Sennoune S, Bakunts K, Martinez G, Chua-Tuan J, Kebir Y, Attaya M . Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol. 2004; 286(6):C1443-52. DOI: 10.1152/ajpcell.00407.2003. View

5.
Stevens T, Forgac M . Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol. 1997; 13:779-808. DOI: 10.1146/annurev.cellbio.13.1.779. View